![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity Initiates Phase 2 Trial of IPI-926 in Patients With Chondrosarcoma
March 03, 2011 08:00 ET
|
Infinity Pharmaceuticals, Inc.
— Company Granted U.S. Orphan Drug Designation for IPI-926 for the Treatment of Chondrosarcoma —
— Rationale for Developing IPI-926 in Chondrosarcoma to be...
![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity Pharmaceuticals to Present at Two Upcoming Conferences
February 28, 2011 08:00 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Feb. 28, 2011 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) will be presenting at the Cowen and Company 31st Annual Health Care Conference on Monday, March 7, 2011...
![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity Initiates Phase 2 Portion of Trial of IPI-926 in Pancreatic Cancer
February 22, 2011 08:00 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Feb. 22, 2011 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) today announced the initiation of the randomized Phase 2 portion of the trial of IPI-926 in combination...
![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity Provides 2011 Goals and Guidance
January 07, 2011 08:01 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Jan. 7, 2011 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) today provided guidance on its anticipated pipeline and business goals for 2011. Infinity begins the...
![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity Pharmaceuticals to Present at 29th Annual J.P. Morgan Healthcare Conference
January 05, 2011 08:30 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Jan. 5, 2011 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) will be presenting at the J.P. Morgan 29th Annual Healthcare Conference on Thursday, January 13, 2011 at...
![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity Elevated to NASDAQ Global Select Market
January 03, 2011 08:00 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Jan. 3, 2011 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) announces that, effective today, it has been named to the NASDAQ Global Select Market tier, the premier...
![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity and Mundipharma Extend Global Strategic Alliance
December 13, 2010 06:30 ET
|
Infinity Pharmaceuticals, Inc.
Mundipharma Commits to Providing Up to $110 Million in R&D Funding for 2012 in Addition to $85 Million Previously Committed for 2011
Companies Agree Upon Event-Based Approach for IPI-926...
![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity Pharmaceuticals to Present at Piper Jaffray Healthcare Conference
November 22, 2010 08:00 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Nov. 22, 2010 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) will be presenting at the Piper Jaffray 22nd Annual "Unplugged" Health Care Conference on Wednesday,...
![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity Conducting Clinical Trial in Patients With Pancreatic Cancer in Denver
November 16, 2010 10:02 ET
|
Infinity Pharmaceuticals, Inc.
Ongoing Clinical Trial Evaluating a New Approach for Pancreatic Cancer, One of the Most Difficult to Treat Cancers
Spotlight on Pancreatic Cancer Awareness Month in November
DENVER, Nov. 16,...
![Infinity Pharmaceuticals, Inc. Logo](/news-release/logo/216379/0/216379.jpg?lastModified=12%2F09%2F2016%2022%3A45%3A34&size=2)
Infinity Conducting Clinical Trial in Patients With Pancreatic Cancer in Boston
November 16, 2010 08:00 ET
|
Infinity Pharmaceuticals, Inc.
– Ongoing Clinical Trial Evaluating a New Approach for Pancreatic Cancer,
One of the Most Difficult to Treat Cancers –
– Spotlight on Pancreatic...